503B Docket

STAQ Pharma, Inc. 503B outsourcing facility · Denver, CO

This is a record of what FDA published, not a rating. Last FDA inspection and Form 483 status below are as published in FDA's registered outsourcing facilities table (as of Sep 30, 2026).

FDA registration record

Listed by FDA asSTAQ Pharma, Inc., Denver, CO
City / stateDenver, CO
FDA's table lists city and state only, not a street address.
Contact phone (as listed by FDA)1-303-921-5789
Initial registration date2/5/2019
Most recent registration date12/18/2025
Outsourcing facilities must re-register annually (Oct 1 – Dec 31) to remain on FDA's list.
Last inspection (FDA table)9/8/2026
Form 483 issued at last inspection?Yes
Recall conducted? (FDA table)No
Action based on last inspectionOpen
“Open” means FDA has not determined whether further action will be taken (per FDA's table notes).
Intends to compound sterile drugs from bulk substancesYes
Self-reported by the facility at registration; FDA notes this information has not been verified by FDA.
Prior compounding inspection history flagYes
FDA footnotes this facility as the subject of at least one previous compounding inspection that resulted in a Form 483, warning letter or other action.

Source: FDA Registered Outsourcing Facilities

Published FDA records

3Form 483 records
0Warning letters
3Recall events (openFDA)
0Uncertain-match items

Counts include only items from FDA's table or exact name + city + state matches. They are counts of published records, not a score. Uncertain matches are shown below but not counted.

State board of pharmacy license lookup

Colorado DORA License Lookup (State Board of Pharmacy) (license lookup)

Search the state board's lookup for this facility's license status and any disciplinary actions. We link to the state-level tool only and do not list license numbers. FDA's table does not include state board actions. Facilities that ship across state lines may also hold non-resident licenses in your state, so check your own state's board too.

Verify directly

Represent this facility? Claim this profile. Claimed profiles never change FDA records.

Timeline of FDA actions

Newest first. Sources: FDA's registration table, FDA's compounding actions page (2019 onward on the live page), and openFDA drug enforcement records. Items marked Uncertain match may relate to a different site or entity and are not counted. How matching works.

  1. Inspection FDA table
    Last inspection per FDA table; Form 483 issued: Yes
    No document link published · FDA registered outsourcing facilities table
  2. Form FDA 483 FDA table
    Form FDA 483 issued, per FDA's registration table (no document link published there)
    No document link published · FDA registered outsourcing facilities table
  3. Recall Matched
    Recall event 97779
    Class III · Ongoing · 3 product line(s) · Recall no. D-0023-2026, D-0024-2026, D-0025-2026
    Recalling firm as listed: STAQ Pharma, Inc., Denver, CO. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date
    openFDA record · openFDA drug enforcement API
  4. FMD-145 letter Matched
    FMD-145 Letter Issued 06/06/2025
    Listed on FDA page under: STAQ Pharma, Inc., Denver, CO - 503B Facility
    No document link published · FDA Compounding: Inspections, Recalls, and other Actions
  5. Recall Matched
    Recall event 93505
    Class II · Completed · 1 product line(s) · Recall no. D-0147-2024
    Recalling firm as listed: STAQ Pharma, Inc., Denver, CO. Reason: STAQ Pharma Inc. received consumer complaints related to leaking bags and other potential bag concerns. Upon investigation, they determine the source of the issue was with the bag manufacturer who released bags Lot # 134142-001A which had failed internal QC tests for leaks.
    openFDA record · openFDA drug enforcement API
  6. FMD-145 letter Matched
    FMD-145 Letter Issued 03/25/2022
    Listed on FDA page under: STAQ Pharma, Inc., Denver, CO - 503B Facility
    No document link published · FDA Compounding: Inspections, Recalls, and other Actions
  7. Recall Matched
    Recall event 89550
    Class I · Terminated · 2 product line(s) · Recall no. D-0633-2022, D-0634-2022
    Recalling firm as listed: STAQ Pharma, Inc., Denver, CO. Reason: Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A
    openFDA record · openFDA drug enforcement API
  8. Form FDA 483 Matched
    483 Issued 09/29/2021 (PDF - 3 MB)
    Listed on FDA page under: STAQ Pharma, Inc., Denver, CO - 503B Facility
    FDA document · FDA Compounding: Inspections, Recalls, and other Actions
  9. FMD-145 letter Matched
    FMD-145 Letter Issued 05/25/2021
    Listed on FDA page under: STAQ Pharma, Inc., Denver, CO - 503B Facility
    No document link published · FDA Compounding: Inspections, Recalls, and other Actions
  10. Form FDA 483 Matched
    483 Issued 09/03/2020 (PDF - 877 KB)
    Listed on FDA page under: STAQ Pharma, Inc., Denver, CO - 503B Facility
    FDA document · FDA Compounding: Inspections, Recalls, and other Actions